Extracellular Vesicles: A Possible Link between HIV and Alzheimer's Disease-Like Pathology in HIV Subjects?
- PMID: 31450610
- PMCID: PMC6769601
- DOI: 10.3390/cells8090968
Extracellular Vesicles: A Possible Link between HIV and Alzheimer's Disease-Like Pathology in HIV Subjects?
Abstract
The longevity of people with HIV/AIDS has been prolonged with the use of antiretroviral therapy (ART). The age-related complications, especially cognitive deficits, rise as HIV patients live longer. Deposition of beta-amyloid (Aβ), a hallmark of Alzheimer's disease (AD), has been observed in subjects with HIV-associated neurocognitive disorders (HAND). Various mechanisms such as neuroinflammation induced by HIV proteins (e.g., Tat, gp120, Nef), excitotoxicity, oxidative stress, and the use of ART contribute to the deposition of Aβ, leading to dementia. However, progressive dementia in older subjects with HIV might be due to HAND, AD, or both. Recently, extracellular vesicles (EVs)/exosomes, have gained recognition for their importance in understanding the pathology of both HAND and AD. EVs can serve as a possible link between HIV and AD, due to their ability to package and transport the toxic proteins implicated in both AD and HIV (Aβ/tau and gp120/tat, respectively). Given that Aß is also elevated in neuron-derived exosomes isolated from the plasma of HIV patients, it is reasonable to suggest that neuron-to-neuron exosomal transport of Aβ and tau also contributes to AD-like pathology in HIV-infected subjects. Therefore, exploring exosomal contents is likely to help distinguish HAND from AD. However, future prospective clinical studies need to be conducted to compare the exosomal contents in the plasma of HIV subjects with and without HAND as well as those with and without AD. This would help to find new markers and develop new treatment strategies to treat AD in HIV-positive subjects. This review presents comprehensive literatures on the mechanisms contributing to Aβ deposition in HIV-infected cells, the role of EVs in the propagation of Aβ in AD, the possible role of EVs in HIV-induced AD-like pathology, and finally, possible therapeutic targets or molecules to treat HIV subjects with AD.
Keywords: Alzheimer’s disease; HAND; HIV; HIV-TAT; beta-amyloid; exosomes; extracellular vesicles (EVs); neurodegeneration.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
Similar articles
-
Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer's disease.J Neurovirol. 2019 Oct;25(5):702-709. doi: 10.1007/s13365-018-0695-4. Epub 2019 Jan 4. J Neurovirol. 2019. PMID: 30610738 Free PMC article. Review.
-
Does HIV infection contribute to increased beta-amyloid synthesis and plaque formation leading to neurodegeneration and Alzheimer's disease?J Neurovirol. 2019 Oct;25(5):634-647. doi: 10.1007/s13365-019-00732-3. Epub 2019 Mar 13. J Neurovirol. 2019. PMID: 30868421 Review.
-
Proteomics of plasma-derived extracellular vesicles reveals S100A8 as a novel biomarker for Alzheimer's disease: A preliminary study.J Proteomics. 2024 Sep 30;308:105279. doi: 10.1016/j.jprot.2024.105279. Epub 2024 Aug 17. J Proteomics. 2024. PMID: 39159863
-
Heat Shock-Induced Extracellular Vesicles Derived from Neural Stem Cells Confer Marked Neuroprotection Against Oxidative Stress and Amyloid-β-Caused Neurotoxicity.Mol Neurobiol. 2022 Dec;59(12):7404-7412. doi: 10.1007/s12035-022-03055-3. Epub 2022 Oct 3. Mol Neurobiol. 2022. PMID: 36190693 Free PMC article.
-
Sphingolipid-Enriched Extracellular Vesicles and Alzheimer's Disease: A Decade of Research.J Alzheimers Dis. 2017;60(3):757-768. doi: 10.3233/JAD-160567. J Alzheimers Dis. 2017. PMID: 27662306 Free PMC article. Review.
Cited by
-
Extracellular vesicles regulate gap junction-mediated intercellular communication and HIV-1 infection of human neural progenitor cells.Neurobiol Dis. 2021 Jul;155:105388. doi: 10.1016/j.nbd.2021.105388. Epub 2021 May 5. Neurobiol Dis. 2021. PMID: 33962010 Free PMC article.
-
Extracellular vesicles released from macrophages modulates interleukin-1β in astrocytic and neuronal cells.Sci Rep. 2023 Feb 21;13(1):3005. doi: 10.1038/s41598-023-29746-y. Sci Rep. 2023. PMID: 36810605 Free PMC article.
-
Mapping the current trends and hotspots of extracellular vesicles in Alzheimer's disease: a bibliometric analysis.Front Aging Neurosci. 2024 Dec 20;16:1485750. doi: 10.3389/fnagi.2024.1485750. eCollection 2024. Front Aging Neurosci. 2024. PMID: 39759397 Free PMC article.
-
Direct interaction between ABCA1 and HIV-1 Nef: Molecular modeling and virtual screening for inhibitors.Comput Struct Biotechnol J. 2021 Jul 1;19:3876-3884. doi: 10.1016/j.csbj.2021.06.050. eCollection 2021. Comput Struct Biotechnol J. 2021. PMID: 34584633 Free PMC article.
-
The emerging mechanism behind viral infections and extracellular vesicles hypotheses leading to neuroinflammation and Alzheimer's disease pathology.Ibrain. 2023 Jan 31;9(1):63-71. doi: 10.1002/ibra.12090. eCollection 2023 Spring. Ibrain. 2023. PMID: 37786515 Free PMC article. Review.
References
-
- Global HIV & AIDS Statistics—2018 Fact Sheet. [(accessed on 18 June 2019)]; Available online: https://www.unaids.org/en/resources/fact-sheet.
-
- HIV Surveillance Report. [(accessed on 18 June 2019)];2016 Available online: https://www.cdc.gov/hiv/pdf/library/reports/surveillance/cdc-hiv-surveil....
-
- Canestri A., Lescure F.-X., Jaureguiberry S., Moulignier A., Amiel C., Marcelin A.G., Peytavin G., Tubiana R., Pialoux G., Katlama C. Discordance between cerebral spinal fluid and plasma HIV replication in patients with neurological symptoms who are receiving suppressive antiretroviral therapy. Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am. 2010;50:773–778. doi: 10.1086/650538. - DOI - PubMed
-
- Peluso M.J., Ferretti F., Peterson J., Lee E., Fuchs D., Boschini A., Gisslén M., Angoff N., Price R.W., Cinque P., et al. Cerebrospinal fluid HIV escape associated with progressive neurologic dysfunction in patients on antiretroviral therapy with well controlled plasma viral load. AIDS Lond. Engl. 2012;26:1765–1774. doi: 10.1097/QAD.0b013e328355e6b2. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous